XENE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.52%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,535,891.27

Xenon Pharmaceuticals Insider Trading History Chart

Xenon Pharmaceuticals Share Price & Price History

^$38.37

▲ +0.53 (1.40%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

Xenon Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/27/2025	Ian Mortimer	CEO	Sell	16,315	$40.50	$660,757.50	31,302
1/24/2025	Ian Mortimer	CEO	Sell	22,468	$40.20	$903,213.60	31,302
12/18/2024	Sherry Aulin	CFO	Sell	18,709	$41.21	$770,997.89
11/22/2024	Gary Patou	Director	Sell	4,891	$41.08	$200,922.28	23,573
3/7/2024	Robin Sherrington	EVP	Sell	7,137	$46.28	$330,300.36	8,398
3/7/2024	Steven Gannon	Director	Sell	13,000	$46.28	$601,640.00	2,000
12/13/2023	Gary Patou	Director	Sell	11,380	$39.29	$447,120.20	23,573
8/24/2023	Dawn Svoronos	Director	Sell	25,000	$38.70	$967,500.00	25,000
5/31/2023	Simon N. Pimstone	Director	Sell	62,526	$38.70	$2,419,756.20	6,000
5/24/2023	Ian Mortimer	CEO	Sell	31,655	$41.41	$1,310,833.55	24,213
3/24/2023	Christopher John Kenney	Insider	Sell	700	$35.01	$24,507.00
3/7/2023	Simon N. Pimstone	Director	Sell	19,232	$36.98	$711,199.36	34,002
11/25/2022	Gary Patou	Director	Sell	1,937	$34.79	$67,388.23	23,573
11/23/2022	Gary Patou	Director	Sell	2,057	$34.33	$70,616.81	23,573
8/15/2022	Simon N. Pimstone	Director	Sell	33,942	$37.76	$1,281,649.92	58,058
8/12/2022	James R. Empfield	EVP	Sell	57,743	$38.31	$2,212,134.33	10,000
8/12/2022	Simon N. Pimstone	Director	Sell	91,135	$38.28	$3,488,647.80	92,000

See Full Table

SEC Filings (Institutional Ownership Changes) for Xenon Pharmaceuticals (NASDAQ:XENE)

95.45% of Xenon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Xenon Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/30/2025	China Universal Asset Management Co. Ltd.	15,353	$0.52M	0.0%	-5.0%	0.020%
4/29/2025	Envestnet Asset Management Inc.	42,850	$1.44M	0.0%	-9.4%	0.056%
4/29/2025	Bank of New York Mellon Corp	251,147	$8.43M	0.0%	+439.0%	0.328%
4/29/2025	GF Fund Management CO. LTD.	1,952	$65K	0.0%	+21.9%	0.003%
4/28/2025	Teacher Retirement System of Texas	17,439	$0.59M	0.0%	-8.6%	0.023%
4/15/2025	Assenagon Asset Management S.A.	241,206	$8.09M	0.0%	+1.1%	0.315%
4/15/2025	SG Americas Securities LLC	8,655	$0.29M	0.0%	-34.9%	0.011%
4/14/2025	Harbor Capital Advisors Inc.	56,591	$1.90M	0.1%	+13.6%	0.074%
3/18/2025	California State Teachers Retirement System	55,492	$2.18M	0.0%	-0.9%	0.072%
2/19/2025	GF Fund Management CO. LTD.	1,601	$63K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	191,852	$7.52M	0.0%	+17.9%	0.252%
2/17/2025	Woodline Partners LP	39,938	$1.57M	0.0%	N/A	0.052%
2/17/2025	Vestal Point Capital LP	810,000	$31.75M	1.9%	-1.8%	1.062%
2/17/2025	Vident Advisory LLC	5,413	$0.21M	0.0%	N/A	0.007%
2/17/2025	Squarepoint Ops LLC	6,554	$0.26M	0.0%	-12.7%	0.009%
2/17/2025	Two Sigma Advisers LP	298,700	$11.71M	0.0%	+9.1%	0.392%
2/17/2025	Two Sigma Investments LP	273,352	$10.72M	0.0%	+12.2%	0.359%
2/17/2025	Tema Etfs LLC	6,111	$0.24M	0.1%	N/A	0.008%
2/17/2025	Stempoint Capital LP	375,845	$14.73M	3.7%	N/A	0.493%
2/17/2025	Sphera Funds Management LTD.	52,097	$2.04M	0.4%	N/A	0.068%
2/17/2025	Polar Capital Holdings Plc	2,697,657	$105.75M	0.6%	+10.3%	3.538%
2/17/2025	MPM Bioimpact LLC	197,212	$7.73M	1.1%	+18.9%	0.259%
2/17/2025	Parkman Healthcare Partners LLC	193,004	$7.57M	1.0%	+0.7%	0.253%
2/17/2025	Occudo Quantitative Strategies LP	11,441	$0.45M	0.1%	+5.8%	0.015%
2/17/2025	Orbimed Advisors LLC	947,877	$37.16M	0.8%	+4.0%	1.243%
2/17/2025	Millennium Management LLC	346,040	$13.57M	0.0%	+65.5%	0.454%
2/17/2025	Janus Henderson Group PLC	2,866,755	$112.43M	0.1%	+12.3%	3.760%
2/17/2025	Granahan Investment Management LLC	182,333	$7.15M	0.3%	-9.2%	0.239%
2/17/2025	Ensign Peak Advisors Inc	26,094	$1.02M	0.0%	-84.0%	0.034%
2/17/2025	D. E. Shaw & Co. Inc.	86,973	$3.41M	0.0%	-57.6%	0.114%
2/17/2025	Driehaus Capital Management LLC	4,520,595	$177.21M	1.5%	-1.6%	5.929%
2/17/2025	Deep Track Capital LP	169,132	$6.63M	0.2%	N/A	0.222%
2/17/2025	Braidwell LP	2,913,964	$114.23M	3.4%	+7.6%	3.822%
2/17/2025	Brevan Howard Capital Management LP	19,005	$0.75M	0.0%	+58.2%	0.025%
2/17/2025	Avidity Partners Management LP	474,000	$18.58M	1.8%	-42.1%	0.622%
2/17/2025	Balyasny Asset Management L.P.	184,580	$7.24M	0.0%	+119.2%	0.242%
2/17/2025	Bank of America Corp DE	106,906	$4.19M	0.0%	-16.1%	0.140%
2/17/2025	Ameriprise Financial Inc.	92,350	$3.62M	0.0%	+39.1%	0.121%
2/17/2025	Algert Global LLC	241,417	$9.46M	0.2%	+9.9%	0.317%
2/17/2025	AXA S.A.	187,796	$7.36M	0.0%	-0.2%	0.246%
2/17/2025	Allostery Investments LP	30,000	$1.18M	1.2%	N/A	0.039%
2/17/2025	Ally Bridge Group NY LLC	129,291	$5.07M	4.3%	-39.0%	0.170%
2/14/2025	Boxer Capital Management LLC	600,000	$23.52M	2.0%	N/A	0.787%
2/14/2025	Schonfeld Strategic Advisors LLC	15,150	$0.59M	0.0%	+11.5%	0.020%
2/14/2025	First Light Asset Management LLC	1,160,580	$45.50M	4.3%	-1.8%	1.522%
2/14/2025	Northern Trust Corp	65,783	$2.58M	0.0%	+51.6%	0.086%
2/14/2025	Tudor Investment Corp ET AL	8,671	$0.34M	0.0%	-76.4%	0.011%
2/14/2025	Quarry LP	2,000	$78K	0.0%	N/A	0.003%
2/14/2025	Aquatic Capital Management LLC	8,260	$0.32M	0.0%	N/A	0.011%
2/14/2025	Boothbay Fund Management LLC	17,395	$0.68M	0.0%	-42.3%	0.023%
2/14/2025	Virtus ETF Advisers LLC	1,802	$71K	0.0%	-25.7%	0.002%
2/14/2025	Nebula Research & Development LLC	20,360	$0.80M	0.1%	-16.1%	0.027%
2/14/2025	Lord Abbett & CO. LLC	194,971	$7.64M	0.0%	+12.1%	0.256%
2/14/2025	Voya Investment Management LLC	62,415	$2.45M	0.0%	+32.3%	0.082%
2/14/2025	Adage Capital Partners GP L.L.C.	1,863,473	$73.05M	0.1%	-10.6%	2.444%
2/14/2025	T. Rowe Price Investment Management Inc.	1,437,831	$56.36M	0.0%	-4.4%	1.886%
2/14/2025	Eversept Partners LP	155,540	$6.10M	0.5%	N/A	0.204%
2/14/2025	Rock Springs Capital Management LP	1,251,859	$49.07M	1.9%	-4.9%	1.642%
2/14/2025	J. Safra Sarasin Holding AG	17,786	$0.70M	0.0%	N/A	0.023%
2/14/2025	Stifel Financial Corp	20,688	$0.81M	0.0%	-4.1%	0.027%
2/14/2025	Tower Research Capital LLC TRC	647	$25K	0.0%	-68.0%	0.001%
2/14/2025	Capital World Investors	2,294,537	$89.95M	0.0%	-14.4%	3.010%
2/14/2025	Dimensional Fund Advisors LP	259,970	$10.19M	0.0%	-13.3%	0.341%
2/14/2025	Capital International Investors	2,547,210	$99.85M	0.0%	-1.3%	3.341%
2/13/2025	Marshall Wace LLP	899,718	$35.27M	0.0%	-24.7%	1.180%
2/13/2025	Affinity Asset Advisors LLC	1,161,237	$45.52M	6.1%	+1.5%	1.523%
2/13/2025	Guggenheim Capital LLC	6,177	$0.24M	0.0%	-41.9%	0.008%
2/13/2025	Walleye Capital LLC	221,982	$8.70M	0.0%	+111.5%	0.291%
2/13/2025	XTX Topco Ltd	8,054	$0.32M	0.0%	N/A	0.011%
2/13/2025	Barclays PLC	18,127	$0.71M	0.0%	+20.9%	0.024%
2/13/2025	Raymond James Financial Inc.	20,331	$0.80M	0.0%	N/A	0.027%
2/13/2025	Renaissance Technologies LLC	13,700	$0.54M	0.0%	-68.9%	0.018%
2/13/2025	Invesco Ltd.	209,554	$8.22M	0.0%	-2.9%	0.275%
2/13/2025	ADAR1 Capital Management LLC	50,547	$1.98M	0.4%	+81.2%	0.066%
2/13/2025	FMR LLC	7,525,290	$294.99M	0.0%	+8.8%	9.871%
2/13/2025	Federated Hermes Inc.	558,500	$21.89M	0.0%	-24.1%	0.733%
2/13/2025	Atika Capital Management LLC	72,600	$2.85M	0.3%	-42.4%	0.095%
2/13/2025	Russell Investments Group Ltd.	213,696	$8.38M	0.0%	-4.4%	0.280%
2/13/2025	Envestnet Asset Management Inc.	47,297	$1.85M	0.0%	-3.2%	0.062%
2/13/2025	Wells Fargo & Company MN	59,520	$2.33M	0.0%	-1.5%	0.078%
2/12/2025	ExodusPoint Capital Management LP	68,884	$2.70M	0.0%	-73.8%	0.090%
2/12/2025	Trexquant Investment LP	11,397	$0.45M	0.0%	-32.6%	0.015%
2/12/2025	Geode Capital Management LLC	69,529	$2.73M	0.0%	+1.0%	0.091%
2/12/2025	Franklin Resources Inc.	575,590	$22.56M	0.0%	+1.7%	0.755%
2/12/2025	Alliancebernstein L.P.	1,443,180	$56.57M	0.0%	+1.3%	1.893%
2/12/2025	Wellington Management Group LLP	3,777,611	$148.08M	0.0%	-1.7%	4.935%
2/12/2025	DnB Asset Management AS	203,243	$7.97M	0.0%	+6.6%	0.267%
2/12/2025	Orion Portfolio Solutions LLC	13,436	$0.53M	0.0%	-7.4%	0.018%
2/12/2025	Pictet Asset Management Holding SA	1,496,511	$58.66M	0.1%	-2.1%	1.963%
2/12/2025	Loomis Sayles & Co. L P	687,145	$26.94M	2.9%	-2.8%	0.901%
2/12/2025	NEOS Investment Management LLC	6,111	$0.24M	0.0%	N/A	0.008%
2/12/2025	BIT Capital GmbH	53,928	$2.11M	0.2%	N/A	0.071%
2/12/2025	JPMorgan Chase & Co.	1,356,895	$53.19M	0.0%	+38.9%	1.780%
2/11/2025	Prudential Financial Inc.	39,000	$1.53M	0.0%	+177.7%	0.051%
2/11/2025	Fox Run Management L.L.C.	8,621	$0.34M	0.1%	-56.3%	0.011%
2/11/2025	KLP Kapitalforvaltning AS	12,800	$0.50M	0.0%	N/A	0.017%
2/11/2025	Magnetar Financial LLC	5,363	$0.21M	0.0%	N/A	0.007%
2/11/2025	Teacher Retirement System of Texas	19,083	$0.75M	0.0%	+18.6%	0.025%
2/10/2025	Thrivent Financial for Lutherans	30,699	$1.20M	0.0%	-28.8%	0.040%
2/10/2025	Natixis Advisors LLC	23,554	$0.92M	0.0%	-13.3%	0.031%

Data available starting January 2016

See Full Table

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Today's Range

Now: $38.37

$36.94

$38.53

50 Day Range

MA: $34.77

$28.23

$39.73

52 Week Range

Now: $38.37

$26.74

$46.00

Volume

944,054 shs

Average Volume

444,188 shs

Market Capitalization

$2.94 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Xenon Pharmaceuticals?: Xenon Pharmaceuticals' top insider investors include:
Ian Mortimer (CEO)
Dawn Svoronos (Director)
Gary Patou (Director)
Sherrington Robin (EVP)
Simon N Pimstone (Director)
Steven Gannon (Director)
Sherry Aulin (CFO)
Learn More about top insider investors at Xenon Pharmaceuticals.
Who are the major institutional investors of Xenon Pharmaceuticals?: Xenon Pharmaceuticals' top institutional shareholders include:
Bank of New York Mellon Corp — 0.33%
Assenagon Asset Management S.A. — 0.32%
Harbor Capital Advisors Inc. — 0.07%
Envestnet Asset Management Inc. — 0.06%
Teacher Retirement System of Texas — 0.02%
SG Americas Securities LLC — 0.01%
Learn More about top institutional investors of Xenon Pharmaceuticals stock.
Which major investors are selling Xenon Pharmaceuticals stock?: During the last quarter, XENE stock was sold by these institutional investors:
SG Americas Securities LLC
Envestnet Asset Management Inc.
Teacher Retirement System of Texas
During the previous year, company insiders that have sold Xenon Pharmaceuticals company stock include:
Ian Mortimer (CEO)
Dawn Svoronos (Director)
Gary Patou (Director)
Learn More investors selling Xenon Pharmaceuticals stock.
Which major investors are buying Xenon Pharmaceuticals stock?: Within the last quarter, XENE stock was bought by institutional investors including:
Bank of New York Mellon Corp
Harbor Capital Advisors Inc.
Assenagon Asset Management S.A.
GF Fund Management CO. LTD.